Editing Endocrine system (section)

===Parathyroid glands===
A lateral and ventral view of an [[embryo]] showing the third (inferior) and fourth (superior) parathyroid glands during the 6th week of embryogenesis

Once the embryo reaches four weeks of gestation, the [[parathyroid gland]]s begins to develop. The human embryo forms five sets of [[endoderm]]-lined pharyngeal pouches. The third and fourth pouch are responsible for developing into the inferior and superior parathyroid glands, respectively. The third pharyngeal pouch encounters the developing thyroid gland and they migrate down to the lower poles of the thyroid lobes. The fourth pharyngeal pouch later encounters the developing thyroid gland and migrates to the upper poles of the thyroid lobes. At 14 weeks of gestation, the parathyroid glands begin to enlarge from 0.1&nbsp;mm in diameter to approximately 1 – 2&nbsp;mm at birth. The developing parathyroid glands are physiologically functional beginning in the second trimester.

Studies in [[Mouse|mice]] have shown that interfering with the [[Hox gene|HOX15]] gene can cause parathyroid gland [[aplasia]], which suggests the gene plays an important role in the development of the parathyroid gland. The genes, [[TBX1]], [[CRKL]], [[GATA3]], [[GCM2]], and [[SOX3]] have also been shown to play a crucial role in the formation of the parathyroid gland. Mutations in TBX1 and CRKL genes are correlated with [[DiGeorge syndrome]], while mutations in GATA3 have also resulted in a [[DiGeorge-like syndrome]]. Malformations in the GCM2 gene have resulted in [[hypoparathyroidism]]. Studies on SOX3 gene mutations have demonstrated that it plays a role in parathyroid development. These mutations also lead to varying degrees of hypopituitarism.